CIPRO ORAL SUSPENSION 500 MG / 5 ML — DIN 02237514
CIPROFLOXACIN : 500 MG / 5 ML · BAYER INC · SUSPENSION · wholesale supply in Canada
Health Canada status: MARKETED
What is CIPRO ORAL SUSPENSION?
CIPRO ORAL SUSPENSION 500 MG / 5 ML contains CIPROFLOXACIN : 500 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02237514, held by BAYER INC, supplied as SUSPENSION for ORAL administration. Health Canada currently lists it as marketed, status dated 15-Sep-1998. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CIPRO ORAL SUSPENSION used for?
Respiratory, urinary tract, skin, bone/joint infections, infectious diarrhea, typhoid fever, uncomplicated gonorrhea, meningococcal carriers, chronic bacterial prostatitis, acute sinusitis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Ciprofloxacin cost around the world?
Ciprofloxacin is listed on 14 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Saudi Arabia | public | 75 | 81 | SAR███.██ |
| South Africa | single exit price | 64 | 81 | ZAR███.██ |
| United States | acquisition | 5 | 52 | USD███.██ |
| Greece | producer price (ex-factory) | 39 | 39 | EUR███.██ |
| Sweden | AIP (pharmacy purchase price) | 10 | 38 | SEK███.██ |
| Bahrain | retail (max) | 20 | 31 | BHD███.██ |
| Romania | max producer price | 20 | 25 | RON███.██ |
| Australia | ex-manufacturer | 11 | 20 | AUD███.██ |
| United Kingdom | hospital | 7 | 7 | GBP███.██ |
| United Arab Emirates | public | 6 | 6 | AED███.██ |
| Hungary | producer price (ex-factory) | 6 | 6 | HUF███.██ |
| Czechia | max producer price (ex-factory) | 2 | 3 | CZK███.██ |
| Austria | KVP (Kassenverkaufspreis) | 2 | 2 | EUR███.██ |
| Iceland | max wholesale | 1 | 1 | ISK███.██ |
392 pack listings across 268 brand entries and 12 price bases, refreshed 08 Sep 2026. Ranges span every Ciprofloxacin pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Ciprofloxacin in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
37 holders have a Canadian DIN containing Ciprofloxacin, across 139 DINs, of which 29 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| SANDOZ CANADA INCORPORATED | 5 | 4 | CIPROFLOXACIN INJECTION USP, CIPROFLOXACIN INTRAVENOUS INFUSION BP, SANDOZ CIPROFLOXACIN | Sourceable in Canada |
| TEVA CANADA LIMITED | 10 | 3 | ACT CIPROFLOXACIN, CIPROFLOXACIN INTRAVENOUS INFUSION, RATIO-CIPROFLOXACIN, TEVA-CIPROFLOXACIN | Sourceable in Canada |
| SUN PHARMA CANADA INC | 3 | 3 | TARO-CIPROFLOX | Sourceable in Canada |
| MARCAN PHARMACEUTICALS INC | 6 | 2 | IPG-CIPROFLOXACIN, MAR-CIPROFLOXACIN | Sourceable in Canada |
| PRO DOC LIMITEE | 5 | 2 | CIPROFLOXACIN-250, CIPROFLOXACIN-500, CIPROFLOXACIN-750, PRO-CIPROFLOXACIN | Sourceable in Canada |
| SIVEM PHARMACEUTICALS ULC | 4 | 2 | CIPROFLOXACIN | Sourceable in Canada |
| AURO PHARMA INC | 3 | 2 | AURO-CIPROFLOXACIN | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 3 | 2 | JAMP-CIPROFLOXACIN | Sourceable in Canada |
| SANIS HEALTH INC | 3 | 2 | CIPROFLOXACIN | Sourceable in Canada |
| BAYER INC | 9 | 1 | CIPRO, CIPRO 100 - TAB 100MG, CIPRO I.V. - LIQ 10MG/ML, CIPRO I.V. MINIBAGS 2MG/ML, CIPRO ORAL SUSPENSION, +1 more | Sourceable in Canada |
| MINT PHARMACEUTICALS INC | 6 | 1 | MINT-CIPROFLOX, MINT-CIPROFLOXACIN | Sourceable in Canada |
| PHARMASCIENCE INC | 5 | 1 | PMS-CIPROFLOXACIN, PMS-CIPROFLOXACIN XL | Sourceable in Canada |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 500 MG / 5 ML |
|---|---|
| Dosage form | SUSPENSION |
| Route | ORAL |
| Pack configuration (monograph) | 100 mL bottle after reconstitution (contains microcapsules and diluent bottles). A teaspoon is provided. |
| Storage | Store at 15-25°C in an upright position. Protect from freezing. Reconstituted suspension stable for 14 days at 5-25°C. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Substance and classification
| Active substance | Ciprofloxacin |
|---|---|
| ATC code | J01MA02 |
| AHFS class | 08:12.18 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02237514 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2237514 |
| Brand name | CIPRO ORAL SUSPENSION |
| Generic / active ingredient | CIPROFLOXACIN : 500 MG / 5 ML |
| Market authorization holder | BAYER INC |
| Health Canada schedule | Prescription |
| ATC code | J01MA02 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J01MA |
| Current status | MARKETED |
| Status date | 15-Sep-1998 |
| Original market date | 1998-09-15 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Adults: 250-750 mg q12h depending on infection. Reconstitute microcapsules with diluent; shake 15s before use. Take 2h before or 6h after antacids/minerals.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to ciprofloxacin or other quinolones; concurrent administration with agomelatine or tizanidine.
Warnings and precautions
Disabling/persistent adverse reactions (tendinitis, neuropathy); QT prolongation; serious hypersensitivity; exacerbation of myasthenia gravis; seizures; hepatic failure; aortic aneurysm risk.
Is Ciprofloxacin in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by SANIS HEALTH INC, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
29 of 139 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACT CIPROFLOXACIN | 250 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 02247339 |
| ACT CIPROFLOXACIN | 750 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 02247341 |
| ACT CIPROFLOXACIN | 500 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 02247340 |
| AURO-CIPROFLOXACIN | 500 MG | TABLET | AURO PHARMA INC | MARKETED | 02381923 |
| AURO-CIPROFLOXACIN | 250 MG | TABLET | AURO PHARMA INC | MARKETED | 02381907 |
| BIO-CIPROFLOXACIN | 500 MG | TABLET | BIOMED PHARMA | MARKETED | 02444887 |
| CIPROFLOXACIN | 250 MG | TABLET | SANIS HEALTH INC | MARKETED | 02353318 |
| CIPROFLOXACIN | 500 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | 02386127 |
| CIPROFLOXACIN | 500 MG | TABLET | SANIS HEALTH INC | MARKETED | 02353326 |
| CIPROFLOXACIN | 250 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | 02386119 |
2 · Same class — other molecules in ATC J01MA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Ciprofloxacin | ACT CIPROFLOXACIN · AG-CIPROFLOXACIN · APO-CIPROFLOX · AURO-CIPROFLOXACIN · +50 more | 139 | 29 | Yes |
| Levofloxacin | ACT LEVOFLOXACIN · APO-LEVOFLOXACIN · AURO-LEVOFLOXACIN · AVA-LEVOFLOXACIN · +19 more | 54 | 16 | Yes |
| Moxifloxacin | AG-MOXIFLOXACIN · APO-MOXIFLOXACIN · APO-MOXIFLOXACIN HYDROCHLORIDE · AURO-MOXIFLOXACIN · +20 more | 25 | 8 | Yes |
| Delafloxacin | BAXDELA | 2 | 2 | Yes |
| Norfloxacin | AVA-NORFLOXACIN · CO NORFLOXACIN · NORFLOXACIN · NORFLOXACINE-400 · +5 more | 12 | 1 | Yes |
| Ofloxacin | FLOXIN I.V. LIQ 20MG/ML · FLOXIN TABLETS 200MG · FLOXIN TABLETS 300MG · FLOXIN TABLETS 400MG · +2 more | 10 | 0 | Not in Canada |
| Gatifloxacin | NOVO-GATIFLOXACIN · TEQUIN · TEQUIN IV | 5 | 0 | Not in Canada |
| Trovafloxacin | TROVAN I.V. · TROVAN TABLETS 100MG · TROVAN TABLETS 200MG | 3 | 0 | Not in Canada |
| Grepafloxacin | RAXAR | 1 | 0 | Not in Canada |
| Gemifloxacin | FACTIVE | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC J01M
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| J01MB | Nalidixic Acid | 1 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is CIPRO ORAL SUSPENSION called?
The same molecule, Ciprofloxacin, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Ciprofloxacin Krka | Latin | Sweden |
| Ciprofloxacin Accord | Latin | Sweden |
| Ciloxan | Latin | Australia, Czechia, Iceland |
| Ciprofloxacin Orion | Latin | Sweden |
| Omacip | Latin | Bahrain, Saudi Arabia |
| CIPROCIN | Latin | Bahrain, Saudi Arabia |
| Ciprofloxacin Hexal | Latin | Sweden |
| Ciprofloxacin SUN | Latin | Sweden |
| CIPROGEN | Latin | Bahrain, Saudi Arabia |
| APO-Ciprofloxacin | Latin | Australia |
| Ciprocina | Latin | South Africa |
| Ciprofloxacin Bluefish | Latin | Sweden |
| Ciprofloxacin Ebb | Latin | Sweden |
| Ciprofloxacin Sandoz | Latin | Australia |
| Ciprofloxacin Viatris | Latin | Sweden |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.